Reata Pharmaceuticals, Inc. ( NASDAQ:RETA – Get Rating )'s share price reached a new 52-week high during trading on Tuesday . The company traded as high as $98.95 and last traded at $98.93, with a volume of 363291 shares traded. The stock had previously closed at $96.64. Analyst Ratings Changes Several research analysts recently commented on RETA shares. Robert W. Baird raised their price target on shares of Reata Pharmaceuticals from $40.00 to $85.00 and gave the company a 'neutral' rating in a report on Wednesday, March 1st.

https://www.dailypolitical.com/2023/04/18/reata-pharmaceuticals-nasdaqreta-hits-new-1-year-high-at-98-95.html

#dailypolitical